APO RESEARCH · REPORT
Albumin
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Product & engineering
Understand the product.
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Selected research
Market Structure
Global Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.
Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.
This report provides an overview of the global Albumin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Albumin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Albumin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albumin market size, projected growth trends, production technologies, key applications, and end-use industries.
Albumin Segment by Company
CSL
Grifols
Shire (Baxalta)
Octapharma
Hualan Bio
CBPO
RAAS
Kedrion
Merck
LFB Group
Albumedix
Thermo Fisher Scientific
Albumin Segment by Type
Human Serum Albumin
Bovine Serum Albumin
Recombinant Albumin
Albumin Segment by Application
Therapeutics
Vaccine Ingredient
Culture Medium Ingredient
Others
Albumin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Albumin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Applications
- Therapeutics
- Vaccine Ingredient
- Culture Medium Ingredient
- Others
Companies covered
- CSL
- Grifols
- Shire (Baxalta)
- Octapharma
- Hualan Bio
- CBPO
- RAAS
- Kedrion
- Merck
- LFB Group
- Albumedix
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Albumin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Albumin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Albumin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Albumin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Albumin Market Dynamics
- 2.1 Albumin Industry Trends
- 2.2 Albumin Industry Drivers
- 2.3 Albumin Industry Opportunities and Challenges
- 2.4 Albumin Industry Restraints
3 Albumin Market by Manufacturers
- 3.1 Global Albumin Revenue by Manufacturers (2021-2026)
- 3.2 Global Albumin Sales by Manufacturers (2021-2026)
- 3.3 Global Albumin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Albumin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Albumin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Albumin Manufacturers, Product Type & Application
- 3.7 Global Albumin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Albumin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Albumin Players Market Share by Revenue in 2025
- 3.8.3 2025 Albumin Tier 1, Tier 2, and Tier 3
4 Albumin Market by Type
- 4.1 Albumin Type Introduction
- 4.1.1 Human Serum Albumin
- 4.1.2 Bovine Serum Albumin
- 4.1.3 Recombinant Albumin
- 4.2 Global Albumin Sales by Type
- 4.2.1 Global Albumin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Albumin Sales by Type (2021-2032)
- 4.2.3 Global Albumin Sales Market Share by Type (2021-2032)
- 4.3 Global Albumin Revenue by Type
- 4.3.1 Global Albumin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Albumin Revenue by Type (2021-2032)
- 4.3.3 Global Albumin Revenue Market Share by Type (2021-2032)
5 Albumin Market by Application
- 5.1 Albumin Application Introduction
- 5.1.1 Therapeutics
- 5.1.2 Vaccine Ingredient
- 5.1.3 Culture Medium Ingredient
- 5.1.4 Others
- 5.2 Global Albumin Sales by Application
- 5.2.1 Global Albumin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Albumin Sales by Application (2021-2032)
- 5.2.3 Global Albumin Sales Market Share by Application (2021-2032)
- 5.3 Global Albumin Revenue by Application
- 5.3.1 Global Albumin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Albumin Revenue by Application (2021-2032)
- 5.3.3 Global Albumin Revenue Market Share by Application (2021-2032)
6 Global Albumin Sales by Region
- 6.1 Global Albumin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Albumin Sales by Region (2021-2032)
- 6.2.1 Global Albumin Sales by Region (2021-2026)
- 6.2.2 Global Albumin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Albumin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Albumin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Albumin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Albumin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Albumin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Albumin Revenue by Region
- 7.1 Global Albumin Revenue by Region
- 7.1.1 Global Albumin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Albumin Revenue by Region (2021-2026)
- 7.1.3 Global Albumin Revenue by Region (2027-2032)
- 7.1.4 Global Albumin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Albumin Revenue (2021-2032)
- 7.2.2 North America Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Albumin Revenue (2021-2032)
- 7.3.2 Europe Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Albumin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Albumin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Albumin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 CSL
- 8.1.1 CSL Company Information
- 8.1.2 CSL Business Overview
- 8.1.3 CSL Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 CSL Albumin Product Portfolio
- 8.1.5 CSL Recent Developments
- 8.2 Grifols
- 8.2.1 Grifols Company Information
- 8.2.2 Grifols Business Overview
- 8.2.3 Grifols Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Grifols Albumin Product Portfolio
- 8.2.5 Grifols Recent Developments
- 8.3 Shire (Baxalta)
- 8.3.1 Shire (Baxalta) Company Information
- 8.3.2 Shire (Baxalta) Business Overview
- 8.3.3 Shire (Baxalta) Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shire (Baxalta) Albumin Product Portfolio
- 8.3.5 Shire (Baxalta) Recent Developments
- 8.4 Octapharma
- 8.4.1 Octapharma Company Information
- 8.4.2 Octapharma Business Overview
- 8.4.3 Octapharma Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Octapharma Albumin Product Portfolio
- 8.4.5 Octapharma Recent Developments
- 8.5 Hualan Bio
- 8.5.1 Hualan Bio Company Information
- 8.5.2 Hualan Bio Business Overview
- 8.5.3 Hualan Bio Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Hualan Bio Albumin Product Portfolio
- 8.5.5 Hualan Bio Recent Developments
- 8.6 CBPO
- 8.6.1 CBPO Company Information
- 8.6.2 CBPO Business Overview
- 8.6.3 CBPO Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 CBPO Albumin Product Portfolio
- 8.6.5 CBPO Recent Developments
- 8.7 RAAS
- 8.7.1 RAAS Company Information
- 8.7.2 RAAS Business Overview
- 8.7.3 RAAS Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 RAAS Albumin Product Portfolio
- 8.7.5 RAAS Recent Developments
- 8.8 Kedrion
- 8.8.1 Kedrion Company Information
- 8.8.2 Kedrion Business Overview
- 8.8.3 Kedrion Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Kedrion Albumin Product Portfolio
- 8.8.5 Kedrion Recent Developments
- 8.9 Merck
- 8.9.1 Merck Company Information
- 8.9.2 Merck Business Overview
- 8.9.3 Merck Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Merck Albumin Product Portfolio
- 8.9.5 Merck Recent Developments
- 8.10 LFB Group
- 8.10.1 LFB Group Company Information
- 8.10.2 LFB Group Business Overview
- 8.10.3 LFB Group Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 LFB Group Albumin Product Portfolio
- 8.10.5 LFB Group Recent Developments
- 8.11 Albumedix
- 8.11.1 Albumedix Company Information
- 8.11.2 Albumedix Business Overview
- 8.11.3 Albumedix Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Albumedix Albumin Product Portfolio
- 8.11.5 Albumedix Recent Developments
- 8.12 Thermo Fisher Scientific
- 8.12.1 Thermo Fisher Scientific Company Information
- 8.12.2 Thermo Fisher Scientific Business Overview
- 8.12.3 Thermo Fisher Scientific Albumin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Thermo Fisher Scientific Albumin Product Portfolio
- 8.12.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Albumin Value Chain Analysis
- 9.1.1 Albumin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Albumin Production Mode & Process
- 9.2 Albumin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Albumin Distributors
- 9.2.3 Albumin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst